All lobbying filings

THE NICKLES GROUP, LLC

Lobbying for NOVO NORDISK, INC. · Pharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $80,000.00 income · posted Apr 17, 2025

Official filing document

Bills named in this filing 3

HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
HR 591
Defending American Jobs and Investment Act
HR 2423
Unfair Tax Prevention Act

Lobbying activity 3

Health Issues

Issues related to compounding and counterfeit drugs.

Medicare/Medicaid

Issues related to drug pricing and implementation of the Inflation Reduction Act. H.R. 1492, the Ensuring Pathways to Innovative Cures Act. Issues related to coverage of anti-obesity medications.

Taxation/Internal Revenue Code

Issues related to the extension of the Tax Cut and Jobs Act provisions impacting corporations. H.R. 591, Defending American Jobs and Investment Act, and H.R. 2423, Unfair Tax Prevention Act, as they relate to multinational corporations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.